| Home | Article Database | Fun Stuff | Resources | Tools & Calculators | Search HY


Ask the Mental Health Expert Archives 2001-2004

Expert Home  |  Archives by Date  |  Search Expert Archives  |  For Professionals  |  For Consumers


Abilify

Q. I work with autistic children. Recently a parent asked if I knew of a new medication on the market called "Abilify". Because it is relatively new, I can't find any information on it. Could you please tell me what the drug does and what the side effects are? Where can I locate information on it?

A. This new antipsychotic medication's generic name is aripiprazole. Aripiprazole has a unique receptor binding profile that combines partial agonist activity at D2 (dopamine-2) and 5HT1A (serotonin) receptors, with potent antagonism at 5HT2A receptors.

Clinical studies in acute schizophrenic relapse, chronic schizophrenia and acute mania show it is sinificantly more effective than placebo. Once-daily aripiprazole 15-30 mg is as effective as haloperidol 10 mg/day and risperidone 6 mg/day in short-term treatment of schizophrenia and more effective than haloperidol 7-10 mg/day in maintenance of response in chronic schizophrenia.

Aripiprazole appears to be well tolerated, with most studies suggesting a frequency of adverse effects similar to placebo. (This may change as clinical experience is gained in real-world patients, rather than research subjects). Unlike many of the other atypical antipsychotics, aripiprazole seems not to cause significant extrapyramidal side effects, prolactin elevation, excessive weight gain, problems with blood sugar, or cardiac rhythm disturbances. For a review of this promising agent, see DM Taylor, Int J Clin Pract. 2003 Jan-Feb;57(1):49-54.

Other Resources:

August 2003

Disclaimer Back to Ask the Expert



 
ADDITIONAL ONLINE RESOURCES FROM CMPMEDICA
Featured Resources > Psychiatry Careers > Today's Practice - Practice Management Resource > Bipolar Depression Infocenter
CancerNetwork > Cancer diagnosis, treatment, and prevention > Podcasts for Oncologists > Cancer Patient Resources > Oncology Areas of Confusion > Oncology News > Cancer Management Handbook > Oncology E-Learning > ASCO Conference Report
Consultant Live > Pediatric Asthma > Practical Clinical Advice > Medical Photoclinic > Diagnosing and Treating H1N1 flu (swine flu) > Primary Care Conference Reports > Community Acquired MRSA
Diagnostic Imaging > Medical Imaging News and Features > Medical Imaging and Radiology White Papers > Radiology Conference Reports > Radiology Special Reports > Radiology Net Seminars > Imaging Trends and Advances > CT Dose Issues and Articles > Molecular Imaging Articles
Psychiatric Times > Psychiatric News and Special Reports > APA Conference Report > Psychiatric Clinical Scales > Psychiatric Times Blog > Psychiatry Career Opportunities > DSM-V
Physicians Practice > Practice Management > EMR Software > Medical Practice Management Software > Medical Buyers Guide > Medical Coding
SearchMedica > Professional Medical Search Engine > Medical Search Tips Newsletter > Medical Search News
CME LLC > Continuing Medical Education > Psychiatry CME > Oncology CME > Practice Management CME > Primary Care CME > Psychiatric Congress > Performance Improvement CME
More Resources > Consumer Healthcare Information > Patient and Caregiver Resource > Search drug information, interactions, images & diagnosis